Alyeska Investment Group
LONA

Alyeska Investment Group’s LeonaBio Inc LONA Stock Holding History

Alyeska Investment Group’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,000
Closed -$3.42M – 727
2020
Q4 		$3.42M Sell
10,000
-18,828
-65% -$4.44M 0.05% 322
2020
Q3 		$5.32M Buy
+28,828
New +$4.82M 0.08% 252

Other funds holding LONA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Alyeska Investment Group's LONA Position: Q1 2021 in Review

Alyeska Investment Group sold out of LeonaBio Inc (LONA) in Q1 2021, closing a stake of 10,000 shares — an estimated $3.42M sold.

Alyeska Investment Group first reported a position in LONA in Q3 2020 and held it in 2 quarters. The position peaked at $5.32M in Q3 2020. 69 funds tracked by Wall St. Rank hold LONA as of Q1 2021.

  • Alyeska Investment Group reported no remaining LeonaBio Inc position as of Q1 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 10,000 LeonaBio Inc shares in Q1 2021, an estimated $3.42M.
  • Alyeska Investment Group first reported a position in LeonaBio Inc in Q3 2020 and held it in 2 quarters.
  • Alyeska Investment Group's LeonaBio Inc position peaked at $5.32M in Q3 2020.
  • 69 funds tracked by Wall St. Rank held LeonaBio Inc as of Q1 2021.

Based on Alyeska Investment Group's 13F filing for Q1 2021, filed 17 May 2021.